NIH-funded research U01 cooperative agreement

Exploring the effects of medical cannabis on breast cancer patients during and after treatment

Official title: Assessing Benefits and Harms of Medical Cannabis and Cannabinoid Use in Breast Cancer Patients During and After Treatments

Funded at University of Miami School of Medicine · NIH-10932275 · Data updated 2026-11-12

This study is looking at how medical cannabis might help or hurt breast cancer patients during and after their treatment, by comparing the experiences of 600 patients who use it with those who don’t, to see how it affects their symptoms and overall health.

More Breast Cancer research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Miami School of Medicine
NIH-funded
Lab location1 site (Coral Gables, United States)
Project startSeptember 20, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$617,738
NIH project number5U01CA286810-02
Project IDNIH-10932275 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are breast cancer patients, particularly those who are using or considering the use of medical cannabis during or after their treatment.

Less likely to help

Patients who are not diagnosed with breast cancer or those who are not interested in using medical cannabis may not benefit from this research.

What this research studies

This research investigates how medical cannabis and cannabinoids (MCC) affect breast cancer patients, particularly focusing on their potential benefits and harms during and after treatment. The study will involve a cohort of 600 breast cancer patients, half of whom use MCC and half who do not, to assess their experiences, treatment-related symptoms, and clinical outcomes. Researchers will collect data on the types of products used, dosage, and frequency, aiming to understand how MCC may alleviate symptoms and interact with cancer treatments. The study also seeks to explore the biological mechanisms behind these effects, particularly targeting inflammation pathways.

Why it matters

Potential benefit: If successful, this research could provide valuable insights into how medical cannabis may improve the quality of life and clinical outcomes for breast cancer patients.

How similar studies have gone: While there is limited research on the specific effects of medical cannabis in breast cancer patients, similar studies in other cancer populations have shown promising results regarding symptom relief and improved quality of life.

Where this research is happening

  • University of Miami School of Medicine
    Coral Gables, United States
    Active

Researchers

  • Principal investigator: Hu, Jennifer J — University of Miami School of Medicine
  • Study coordinator: Hu, Jennifer J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.